ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,174Medicare Part D Prescriptions Filled, Including Refills

Rank: 68 out of 229

$524K Total Retail Price of All Prescriptions

Rank: 43 out of 229

610 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 610 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

4% of this provider’s 610 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 6,629 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
SIMVASTATIN 596 568 1 3
LEVOTHYROXINE SODIUM 548 514 2 1
METFORMIN HCL 236 205 3 6
OMEPRAZOLE 222 215 4 4
LISINOPRIL 214 207 5 2
ENALAPRIL MALEATE 199 168 6 54
AMLODIPINE BESYLATE 197 191 7 5
ATORVASTATIN CALCIUM 183 171 8 15
SERTRALINE HCL 129 126 9 22
METOPROLOL SUCCINATE 123 118 10 16
ATENOLOL 119 102 11 19
HYDROCHLOROTHIAZIDE 108 106 12 9
LOVASTATIN 105 93 13 11
LOSARTAN POTASSIUM 94 81 14 12
NAMENDA 83 83 15 39
DONEPEZIL HCL 82 80 16 29
EVISTA 80 71 17 106
DIOVAN 79 77 18 42
PRAVASTATIN SODIUM 78 78 19 25
CITALOPRAM HBR 75 70 20 21
GABAPENTIN 75 64 20 10
METOPROLOL TARTRATE 74 66 22 13
PAROXETINE HCL 73 73 23 49
CIPROFLOXACIN HCL 72 66 24 58
FLUOXETINE HCL 68 62 25 41
CRESTOR 68 58 25 30
FLUTICASONE PROPIONATE 64 64 27 23
FUROSEMIDE 60 52 28 8
POTASSIUM CHLORIDE 60 47 28 18
FENOFIBRATE 56 37 30 68
PANTOPRAZOLE SODIUM 53 48 31 33
ALENDRONATE SODIUM 53 53 31 14
LOSARTAN-HYDROCHLOROTHIAZIDE 52 52 33 65
LANTUS SOLOSTAR 51 44 34 85
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 12, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.